By Kuldip K. Ambastha
The stock of GoodRx Holdings, Inc. (GDRX), a digital healthcare platform operator, dropped by -38.9% for the trading day of Tuesday, March 1, 2022. GoodRx was founded in 2011 and went public in 2020 – thus, the company’s stock has a short history of being publicly traded. The stock price dropped on Tuesday since the most recent quarterly update by corporate leadership was disappointing, with key metrics such as earnings and revenues not meeting Wall Street consensus estimates. Accordingly, many equity research analysts have downgraded the stock and / or set a lower price target for the stock going forward. The future outlook for GoodRx is negative here at the moment, but as always a company and its stock could surprise Wall Street in a positive way in the future.
Keywords – GoodRx Holdings, Inc., GoodRx Holdings, GoodRx, GDRX, digital, healthcare, platform, operator, price, earnings, revenues, Wall Street, equity research, analysis, consensus, estimates, downgrade, target, future, surprise.
Disclosure – The principals and clients of Ambastha Financial LLC have no positions in GDRX.
Disclaimer – No recommendations are being made via this post. Past performance is not an indicator of future performance. As an investor, you should do your own research and seek professional advice from a Registered Investment Adviser (RIA). You can lose money by investing in stocks and other instruments. Ambastha Financial LLC does not assume any responsibility (legal or otherwise) for any losses that may occur as a result of actions taken based on this post. All content copyrighted © 2022 – Ambastha Financial LLC.
CONTACT US